For the Inventor, By the Inventor

Enter assignee name

Malvern, PA, United States of America

Endo Pharmaceuticals Inc.

USPTO Granted Patents = 32

CIPO Patents = 9

EPO Patents = 6

Trademarks = 53

Forward Citations = 407

Loading Chart...

Loading Chart...

66 inventors (with patents filed for the assignee):

Anand R Baichwal (11 out of 50 patents)

Philip A Goliber (6 out of 7 patents)

Thomas Sciascia (6 out of 13 patents)

4. Anthony E Carpanzano (6 out of 10 patents)

5. Donald Diehl (6 out of 7 patents)

6. Brian Vogler (6 out of 7 patents)

7. David Verbel (4 out of 12 patents)

8. Stanley Au (4 out of 5 patents)

9. Troy McCall (4 out of 5 patents)

10. Frank S Caruso (4 out of 23 patents)

11. Harry Ahdieh (3 out of 3 patents)

12. David Lee (3 out of 3 patents)

13. Roger Astbury Smith (3 out of 75 patents)

14. Huai-Hung D Kao (3 out of 15 patents)

15. Subramanya Hosahalli (2 out of 17 patents)

32 patents: Sort by Forward Citations

1. 11389443 - Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment (2022-07-19),

2. 10406106 - Sustained release formulations of nalbuphine (2019-09-10),

3. 10251908 - [object Object] (2019-04-09),

4. 10172798 - Sustained release formulation of nalbuphine (2019-01-08),

5. 10052344 - [object Object] (2018-08-21),

6. 9926328 - Crystalline, anhydrous forms of oxymorphone hydrochloride (2018-03-27),

7. 9820982 - Oxymorphone controlled release formulations (2017-11-21),

8. 9789103 - Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment (2017-10-17),

9. 9440986 - Crystalline, anhydrous forms of oxymorphone hydrochloride (2016-09-13),

10. 9351938 - Sustained release formulation of nalbuphine (2016-05-31),

11. 9278076 - Chronotherapeutic dosage forms (2016-03-08),

12. 9186330 - Sustained release formulation of nalbuphine (2015-11-17),

13. 9050163 - Urethral anastomosis device and method (2015-06-09),

14. 8808737 - Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment (2014-08-19),

15. 8771732 - Sustained release formulations of nalbuphine (2014-07-08),

Endo Pharmaceuticals Inc. is a global specialty pharmaceutical company committed to improving patients' lives. They develop, manufacture, and market high-quality branded and generic prescription drugs used in a variety of therapeutic areas. With a diverse portfolio of products, Endo Pharmaceuticals focuses on meeting the needs of patients and healthcare professionals by providing innovative treatment options. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

32 Patents

#20 in Malvern, PA

#382 in Pennsylvania

#10,247 in US

#20,095 in the World

Malvern, PA, United States of America

Endo Pharmaceuticals Inc.

Forward Citations = 407

66 inventors:

Anand R Baichwal (11 out of 50 patents)

Philip A Goliber (6 out of 7 patents)

Thomas Sciascia (6 out of 13 patents)

4. Anthony E Carpanzano (6 out of 10 patents)

5. Donald Diehl (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…